Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Solid Tumour × Clear all

Status

Sponsor Class

Study Type

Interventional 7 Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 2889 Neoplasms 2595 Lung Neoplasms 1352 Colorectal Neoplasms 1313 Prostatic Neoplasms 1203 Carcinoma, Non-Small-Cell Lung 1068 Carcinoma, Hepatocellular 771 Stomach Neoplasms 708 Pancreatic Neoplasms 687 Ovarian Neoplasms 580 Colonic Neoplasms 532 Uterine Cervical Neoplasms 494 Head and Neck Neoplasms 491 Rectal Neoplasms 470 Melanoma 464 Multiple Myeloma 457 Esophageal Neoplasms 417 Neoplasm Metastasis 416 Brain Neoplasms 403 Lymphoma 397 Precursor Cell Lymphoblastic Leukemia-Lymphoma 395 Urinary Bladder Neoplasms 381 Leukemia, Myeloid, Acute 380 Leukemia 339 Carcinoma, Renal Cell 329 Liver Neoplasms 315 Endometrial Neoplasms 313 Hematologic Neoplasms 311 Recurrence 291 Disease 266

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01627990 2015-07-24

Nivestim™ in Treatment of Malignant Diseases

Hospira, now a wholly owned subsidiary of Pfizer

Other solid neoplasm

Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡